Jazz Pharmaceuticals
JAZZ
JAZZ
453 hedge funds and large institutions have $6.14B invested in Jazz Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 62 funds opening new positions, 159 increasing their positions, 163 reducing their positions, and 82 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
453
Holders Change
-24
Holders Change %
-5.03%
% of All Funds
6.59%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.09%
New
62
Increased
159
Reduced
163
Closed
82
Calls
$27.7M
Puts
$17.2M
Net Calls
+$10.6M
Net Calls Change
+$15M
Top Buyers
| 1 |
Swedbank
Stockholm,
Sweden
|
+$107M |
| 2 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$65.8M |
| 3 |
Capital World Investors
Los Angeles,
California
|
+$63.2M |
| 4 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$56.3M |
| 5 |
BG
Baupost Group
Boston,
Massachusetts
|
+$47M |
Top Sellers
| 1 |
BlackRock
New York
|
-$98.6M |
| 2 |
Fuller & Thaler Asset Management
San Mateo,
California
|
-$65.7M |
| 3 |
State Street
Boston,
Massachusetts
|
-$47.5M |
| 4 |
Pictet Asset Management
Carouge,
Switzerland
|
-$33M |
| 5 |
Morgan Stanley
New York
|
-$26M |
